loading page

Procedural Sedation for Pediatric Patients with Spinal Muscular Atrophy Undergoing Intrathecal Treatment
  • Feyza Sever,
  • Sengül Özmert,
  • Nefise Arıbaş Öz
Feyza Sever
Ankara Şehir Hastanesi

Corresponding Author:feyza.altay@hotmail.com

Author Profile
Sengül Özmert
Ankara Şehir Hastanesi
Author Profile
Nefise Arıbaş Öz
Ankara Şehir Hastanesi
Author Profile

Abstract

Aims: Nusinersen is administered intrathecally for treating spinal muscular atrophy (SMA). Procedural sedation is common with intrathecal treatment in children. This retrospective study presents our experience with procedural sedation during the intrathecal treatment of pediatric patients with SMA I, II, and III. Methods: Data were collected the from the anesthesia charts and electronic medical records of 14 pediatric patients with SMA types I, II, and III who underwent procedural sedation for repeated intrathecal treatments for SMA. Intravenous induction was performed, and patients were oxygenated with a face mask or nasal cannula while spontaneous breathing continued. Results: Fourteen patients were included in the study: one SMA I, eight SMA II, and five SMA III. They underwent 88 intrathecal nusinersen injections totally. In the one SMA I patient, of eight months, the procedure was performed under local anesthesia. In all other patients, the treatments were performed under procedural sedation. Different combinations of midazolam, ketamine, propofol, fentanyl, and remifentanil were used. The mean doses of the agents used were 0.03 mg/kg, 0.97 mg/kg, 2.71 mg/kg, 0.84 mcg/kg and 0.5 mcg/kg respectively. There were no intraoperative or postoperative complications. Conclusion: We found the procedural sedation to be sufficient, effective, and safe in SMA II and III pediatric patients who underwent nusinersen treatment intrathecally, provided anesthetic agents are titrated.and administered carefully.
31 Oct 2022Submitted to British Journal of Clinical Pharmacology
08 Nov 2022Submission Checks Completed
08 Nov 2022Assigned to Editor
08 Nov 2022Review(s) Completed, Editorial Evaluation Pending
22 Nov 2022Reviewer(s) Assigned
16 Jan 2023Editorial Decision: Revise Major
23 Feb 20231st Revision Received
24 Feb 2023Submission Checks Completed
24 Feb 2023Assigned to Editor
24 Feb 2023Review(s) Completed, Editorial Evaluation Pending
06 Mar 2023Editorial Decision: Revise Minor
08 Mar 20232nd Revision Received
09 Mar 2023Submission Checks Completed
09 Mar 2023Assigned to Editor
09 Mar 2023Review(s) Completed, Editorial Evaluation Pending
13 Mar 2023Editorial Decision: Accept